Timothy T. Chole
Corporate Officer/Principal chez ROCKWELL MEDICAL, INC.
Fortune : 45 042 $ au 31/05/2024
Profil
Timothy T.
Chole is currently the Chief Commercial Officer at Rockwell Medical, Inc. He previously worked as the Marketing Director at Gambro AB and as the Director-Product Marketing at Cochlear Americas.
Mr. Chole completed his undergraduate degree at the University of California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0,08% | 21/05/2024 | 25 665 ( 0,08% ) | 45 042 $ | 31/05/2024 |
Postes actifs de Timothy T. Chole
| Sociétés | Poste | Début |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Corporate Officer/Principal | 30/05/2024 |
Anciens postes connus de Timothy T. Chole
| Sociétés | Poste | Fin |
|---|---|---|
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Sales & Marketing | 01/10/2013 |
| Cochlear Americas | Corporate Officer/Principal | - |
Formation de Timothy T. Chole
| University of California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
| Cochlear Americas |
